Research paperEpstein-Barr virus-induced transformation of human B lymphocytes: the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations
-
Add time:08/30/2019 Source:sciencedirect.com
Epstein-Barr virus-mediated transformation of human B lymphocytes is inhibited by human T lymphocytes as well as by interferon-γ. Removal of the inhibitory cell populations is essential in order to achieve successful transformation in vitro. Cells with the capacity to inhibit outgrowth of lymphoblastoid cell lines can be removed by pretreatment of peripheral blood mononuclear cells with l-leucyl-l-leucine methyl ester. This treatment eliminates monocytes, NK-cells and a CD8+ T cell subpopulation. We now show that such treatment also has toxic effects on other human T cell populations. In addition, CD4+ and/or CD8+ lymphocytes are demonstrated to contain effector cell activities which inhibit outgrowth of EBV-transformed B cells. This inhibitory activity is abolished after treatment of peripheral blood mononuclear cells or purified CD4+ T cells with l-leucyl-l-leucine methyl ester. No evidence was found for a selective toxicity against any subset within the CD4+ or CD8+ T cell populations. However, the capacity of the treated cells, both peripheral blood mononuclear cells and purified CD4+ T lymphocytes, to produce mRNA encoding IFN-γ, a protein previously shown to downregulate outgrowth of EBV-transformed B cells, was selectively impaired. The results obtained suggest a role for CD4+ T cells to inhibit EBV-induced transformation of B cells.
We also recommend Trading Suppliers and Manufacturers of leucyl-leucine-methyl ester (cas 13022-42-9). Pls Click Website Link as below: cas 13022-42-9 suppliers
Prev:Regular ArticleSynthesis of Caged Compounds of L-Leucyl-L-Leucine Methyl Ester, an Apoptosis Inducer, and Their Cytotoxic Activity
Next:Design, synthesis, photochemical properties and cytotoxic activities of water-Soluble caged l-Leucyl-l-leucine methyl esters that control apoptosis of immune cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical ResearchAntiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease09/05/2019
- Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk09/04/2019
- Treatment of donor cells with l-leucyl-l-leucine methyl ester prevents induction of graft-vs-host-like reaction in [lprlpr → +/+] chimera09/03/2019
- Regular ArticleSynthesis and Cytotoxic Studies of 5-O-(β–Glucopyranosyl)-2-nitrobenzyl Cagedl-Leucyl-l-Leucine Methyl Ester with Increased Solubility in PBS Containing 1% DMSO☆☆☆09/02/2019
- Original ArticleEffects of the Immunosuppressive Dipeptide L-Leucyl-L-Leucine O-Methyl Ester on Epidermal Langerhans Cells09/01/2019
- Design, synthesis, photochemical properties and cytotoxic activities of water-Soluble caged l-Leucyl-l-leucine methyl esters that control apoptosis of immune cells08/31/2019
- Regular ArticleSynthesis of Caged Compounds of L-Leucyl-L-Leucine Methyl Ester, an Apoptosis Inducer, and Their Cytotoxic Activity08/29/2019
- Regular ArticleCell-Type Specificity of l-Leucyl l-Leucine Methyl Ester08/28/2019


